CoChat

CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis

Fang, Yuanyuan, Li, Zhengtao, Wang, Xiuxia, Zhang, Shulan · 2012 · Tumor Biology

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

CIP2A is a recently characterized oncoprotein which involves in the progression of several human malignancies. This study aimed to investigate its clinical significance and biological function in ovarian cancer. CIP2A expression was analyzed in 152 archived ovarian cancer specimens using immunohistochemistry. One hundred cases (65.79 %) showed CIP2A overexpression, including 63 of 92 serous carcinomas (68.48 %), 21 of 33 endometrioid carcinomas (63.64 %), 12 of 23 mucinous carcinomas (52.17 %), and 4 of 4 clear cell carcinomas (100 %). There is no significant difference of CIP2A expression between serous tumors and all other morphologies combined. CIP2A overexpression positively correlated with advanced FIGO stage (p = 0.0336) and tumor grade (p = 0.0213). siRNA knockdown was performed in A2780 and SKOV3 cell lines. MTT, colony formation assay, and flow cytometry were carried out to assess the role of CIP2A in proliferation, cell cycle, and apoptosis. CIP2A depletion in ovarian cancer cell lines inhibited proliferation, blocked cell cycle progression, and increased paclitaxel-induced apoptosis. Furthermore, CIP2A depletion downregulated cyclin D1, c-myc, phospho-Rb, Bcl-2, and phospho-AKT expression. These results validate the role of CIP2A as a clinically relevant oncoprotein and establish CIP2A as a promising therapeutic target of ovarian cancer.

Overview

Integrity signals

Registry

Crossref · 10.1007/s13277-012-0492-2

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 44

Metadata

Authors
Fang, Y., Li, Z., Wang, X., & Zhang, S.
Affiliations
Sheng Jing Hospital (CN)
Corresponding author
Zhang, Shulan
Venue
Tumor Biology
Published
2012-08-25
Volume
33
Issue
6
Pages
2299-2306
ISSN
  • 1010-4283 (ISSN-L)
  • 1423-0380
OpenAlex
W2046057377
Cited by
40
References
28
Citations by year
2025: 4 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2017: 4 · 2016: 2 · 2015: 8 · 2014: 6 · 2013: 5
FWCI
7.07
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Tumor Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China
Topics
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Keywords
CIP2A, ovarian cancer, oncoprotein, protein overexpression, cell proliferation, apoptosis, cell cycle, paclitaxel, cyclin D1, c-Myc, retinoblastoma protein phosphorylation, Bcl-2, Akt, therapeutic target, serous carcinoma, tumor stage and grade
MeSH terms
Autoantigens, Adenocarcinoma, Mucinous, Cell Cycle, Colony-Forming Units Assay, Female, Flow Cytometry, Humans, Immunoenzyme Techniques, Membrane Proteins, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Ovarian Neoplasms, Prognosis, RNA, Messenger, Tumor Cells, Cultured, Biomarkers, Tumor, Blotting, Western, Endometrial Neoplasms, Apoptosis, Adenocarcinoma, Clear Cell, Cystadenocarcinoma, Serous, Reverse Transcriptase Polymerase Chain Reaction, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Neoplasm Grading, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis. https://app.cochat.ai/papers/10.1007/s13277-012-0492-2
The paper
Fang, Y., Li, Z., Wang, X., & Zhang, S. (2012). CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis. Tumor Biology. https://doi.org/10.1007/s13277-012-0492-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.